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Abstract
Background: A symposium on the mechanisms of action of inhaled airborne particulate matter
(PM), pathogenic particles and fibers such as silica and asbestos, and nanomaterials, defined as
synthetic particles or fibers less than 100 nm in diameter, was held on October 27 and 28, 2005,
at the Environmental Protection Agency (EPA) Conference Center in Research Triangle Park,
North Carolina. The meeting was the eighth in a series of transatlantic conferences first held in
Penarth, Wales, at the Medical Research Council Pneumoconiosis Unit (1979), that have fostered
long-standing collaborations between researchers in the fields of mineralogy, cell and molecular
biology, pathology, toxicology, and environmental/occupational health.
Results: The goal of this meeting, which was largely supported by a conference grant from the
NHLBI, was to assemble a group of clinical and basic research scientists who presented and
discussed new data on the mechanistic effects of inhaled particulates on the onset and development
of morbidity and mortality in the lung and cardiovascular system. Another outcome of the meeting
was the elucidation of a number of host susceptibility factors implicated in adverse health effects
associated with inhaled pathogenic particulates.
Conclusion: New models and data presented supported the paradigm that both genetic and
environmental (and occupational) factors affect disease outcomes from inhaled particulates as well
as cardiopulmonary responses. These future studies are encouraged to allow the design of
appropriate strategies for prevention and treatment of particulate-associated morbidity and
mortality, especially in susceptible populations.
Background
Inhaled durable particles and fibers (defined has having a
greater than 3:1 length to diameter ratio) have been of
concern to human health for over a century due to a myr-
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iad of publications reporting lung diseases in trade work-
ers and miners prior to the enforcement of permissible
exposure levels in the workplace. Although naturally
occurring minerals such as asbestos and silica have been
studied clinically and experimentally for many years, it is
now clear that inhaled ambient particles also are associ-
ated with adverse health effects in man and animals, and
their compositional components and biologic effects are
now under intense investigation. Because synthetic nano-
materials often occur in size ranges similar to ultrafine air-
borne particles that are considered to be a major factor
contributing to adverse health effects of air pollution,
information on the biological reactivity of these particu-
lates is also necessary to allow their safety evaluation.
The goal of this symposium was to understand the mech-
anisms of action of inhaled particulate matter, known
pathogenic minerals, and nanomaterials from presenta-
tion of data generated in a number of laboratories in
academia, government, and industry. The thematic ses-
sions included: 1) Airborne Particulate Matter-Cardiopul-
monary Effects and Host Susceptibility Factors, 2) Metals
and Metal Mixtures as Pathogenic Components of Partic-
ulate Matter, 3) Mechanisms of Asbestos-Induced Cell
Injury and Remediation, 4) Occupational, Environmental
and Genetic Factors in the Development of Disease by
Fibrogenic Minerals and Cigarette Smoke, and 5) Nano-
particles and Nanomedicine. A recurrent theme through-
out the conference was the role of oxidant stress and
antioxidant status in response and host susceptibility to
particle and fiber effects. Reactive oxygen species (ROS)
production is only one of a number of signatures and
repercussions of oxidant stress induced by inhaled parti-
cles and metals in cells and tissues. Information suggests
that biomarkers of oxidative stress and therapeutic strate-
gies targeting ROS and inflammation are ripe areas for
prediction of risk and therapy of particle-induced dis-
eases. This synopsis encompasses information presented
at platform presentations, although a number of out-
standing and relevant poster presentations were also fea-
tured at the meeting. We also reference recently published
articles by investigators that were covered, in part or full,
in their presentations.
This synopsis encompasses information presented at plat-
form presentations, although a number of outstanding
and relevant poster presentations were also featured at the
meeting. We also reference recently published articles by
investigators that were covered, in part or full, in their
presentations.
Results
Airborne particulate matter – cardiopulmonary effects and 
host susceptibility factors
Airborne particulate matter (PM) from vehicle exhaust,
combustion, road dust and windblown soil, has been
associated with increases in respiratory and cardiac mor-
bidity and mortality. PM can occur as coarse particles with
a diameter of more than 2.5 μm that generally are derived
from natural sources such as soil and sea salts, whereas
fine (0.1 to 2.5 μm in diameter) and ultrafine (< .1 μm in
diameter) PM occurs as by-products of combustion of fos-
sil fuels. The complexity and seasonal variations of the
many components of PM which include metals, nitrates,
sulfates, and organic hydrocarbons, make it difficult to
identify the precise toxic species that contribute to inflam-
mation, lung disease and cardiovascular effects. However,
ultrafine particles, a major component of vehicle emis-
sions that are increased in urban air, may be more patho-
genic after inhalation as they have a large surface area per
unit mass, a proportionally higher content of toxic hydro-
carbons, and increased ability to penetrate into lung tis-
sue. Moreover, inhalation of PM interferes with bacterial
inactivation and clearance from the lung.
Clinical ramifications of high PM exposures include air-
way inflammation, exacerbation of asthma, chronic bron-
chitis and airway obstruction. Large cohort studies also
suggest that pollution may increase lung cancer risk [1]. In
addition, cardiovascular effects of episodic high levels of
PM include stroke, heart attacks, heart arrhythmias, and
sudden death. Healthy volunteers as well as potentially
susceptible populations, including the elderly and indi-
viduals with asthma or chronic obstructive pulmonary
disease (COPD), have been evaluated to understand the
mechanisms of cardiopulmonary dysfunction. Exposure
to PM from brake wear and engine emissions in cars and
patrol vehicles is associated with cardiovascular effects in
healthy young men [2] and onset of myocardial infarction
[3], and age and other susceptibility factors may exacer-
bate risks.
Both clinical and animal studies implicate oxidative stress
and impairment of antioxidant defenses as risk factors in
PM-induced cardiovascular responses. Recently, examina-
tion of subjects for changes in heart rate variability (HRV)
revealed that effects of PM occurred predominantly in
people who were missing the glutathione S-transferase
M1 (GSTM1) gene, or were obese or hypertensive [4].
Based upon interactions between the development of
obesity and asthma, obesity might also be a risk factor in
PM-induced exacerbation of asthma. Diabetes also
enhances PM-associated impairment in vascular reactivity
and endothelial function [5]. Increases in PM did not
affect HRV in patients on angiotensin converting enzyme
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(ACE) inhibitors or statins, suggesting that these treat-
ments might ameliorate the adverse cardiac effects of PM.
Although several groups of researchers have shown that
cardiac effects can occur in rodents and dogs after acute
exposures to concentrated airborne particulates (CAPS), a
recent study demonstrates that long-term (6 month)
exposure to New York PM at approximately 10× ambient
concentrations enhances the formation of atherosclerotic
plaques and altered vasomotor tone in susceptible,
atherosclerosis-prone mice (Apo E-/- mice) [6]. The fact
that atherosclerosis was accelerated in these mice also
demonstrating increases in lung and vascular inflamma-
tion, suggests that lung-generated cytokines or other
mediators may systemically activate inflammatory cas-
cades in vessel walls. These signaling and inflammatory
pathways need to be characterized both in cells of the lung
and in the cardiovascular system.
How airborne particulates initially deposited in the lung
might influence the formation of thrombi in the periph-
eral circulation has been explored in a hamster model of
femoral vein thrombus formation [7]. In this model,
intratracheal administration of diesel exhaust particles
(DEP) leads to enhanced thrombus formation within one
hour, a phenomenon attributed to translocation of parti-
cles from the lungs into the circulation. The prothrom-
botic effects of DEP were associated with platelet
activation and mitigated by pretreatment with diphenhy-
dramine (an H1-histamine receptor antagonist), dexame-
thasone or sodium cromoglycate, a mast cell stabilizer.
Transition metal content of PM has emerged as an impor-
tant risk factor in the prevalence of allergic asthma in chil-
dren and airway inflammation/oxidative stress in lungs of
healthy subjects. Toxicogenomic and proteomic studies
[8-10] in animal and cell culture models of PM exposure
show that both metal ion content and oxidation state are
important in determining the bioreactivity of PM. After
intratracheal instillation into rats of metal ions identified
in the soluble fractions of both historic and present day
London PM samples [8], gene profiling of lung and heart
tissues demonstrates transient changes in gene expression,
primarily associated with xenobiotic metabolism and
antioxidant recycling, in heart that are less robust than
changes found in the lung.
An in vitro cellular hierarchical oxidative stress model
using proteomics demonstrates 3 tiers of dose-related
responses to DEP, organic DEP extracts, and ambient
ultrafine particles [11]. At the lowest levels of oxidative
stress (Tier 1), induction of phase II antioxidant and
detoxification enzymes occurs that involves activation of
the transcription factor Nrf2, which drives the antioxidant
response element (ARE) in the promoter of phase II genes.
These phase II enzymes protect against PM-induced proin-
flammatory (Tier 2) and cytotoxic (Tier 3) effects at higher
concentrations. However, compromised Tier 1 responses
or exacerbated Tier 2 and 3 responses may increase indi-
vidual susceptibility to DEP whereas enhanced phase II
enzyme expression may promote adaptation or resistance.
The net outcome of these responses in lung may govern
the extent of small airway remodeling or disease that
occurs after high level chronic exposures to PM. These
mechanistic events are being elucidated in a rat tracheal
organ culture model after exposure to PM or DEP [12]. In
this model, both PM and DEP induce procollagen gene
expression and increased hydroxyproline, a marker of col-
lagen deposition that can be prevented with the TGF-β1
antagonist, fetuin (α2-HS-glycoprotein). Experiments
using both particulates and cigarette smoke indicate that
oxidative activation of TGF-β1 is a critical feature of small
airway remodeling by all agents.
Novel in vivo imaging approaches demonstrate oxidative
stress directly in heart and in the spinotrapezius muscle of
rats after intratracheal instillation of residual oil fly ash
(ROFA). Oxidative stress in the systemic microvascular
wall coincides with adhesion of PMNs, deposition of
myeloperoxidase (MPO), and impairment of endothe-
lium-dependent arteriolar dilation [13,14]. These results
are consistent with studies showing increases in lung and
heart chemiluminescence, an indication of oxidant stress,
and tissue-specific increases in activity of antioxidant
enzymes [15], suggesting adaptive or defense responses in
rats after inhalation of Concentrated Airborne Particulates
(CAPS). The fact that administration of N-acetylcysteine
prevents oxidative stress measured by accumulation of
thiobarbituric reactive substances in lung, as well as lung
inflammation in this model [16], implicates oxidants as
mediators of acute effects of PM in lung.
Metals and metal mixtures as pathogenic components of 
PM
The major metallic components of PM include iron, sili-
con, aluminum, copper, and zinc, and a number of stud-
ies suggest that some of these metals, especially iron,
initiate redox reactions that are implicated in inflamma-
tion and adverse health effects. PMs and their metal com-
ponents can be regionally very different, and not all PM
from individual regions contains the same amount and
type of metal. Thus, the precise delineation of certain met-
als as mediators of inflammation and disease causation is
difficult. Moreover, interactions between metal mixtures
and other components of PM may also be confounding.
Signaling pathways elicited by metallic components of
PM, including zinc (Zn2+) and vanadium (V5+), also may
be critical in redox regulation of protein tyrosine phos-
phatases (PTPs) inactivating the mitogen activated pro-
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tein kinases (MAPKs) or epidermal growth factor receptor
(EGFR) [17,18]. In human airway epithelial cells in vitro,
these metals stimulate kinase activity by impairing EGFR
and MAPK-directed dephosphorylation, probably by a
redox mechanism attacking sulfhydryl (SH) groups on
phosphatases. Thus, Zn2+ and V5+ appear to inhibit critical
phosphatases that normally control aberrant signaling
events leading to cell proliferation and stress rather than
acting directly to stimulate kinase phosphorylation. These
findings may be important in the design of preventive and
therapeutic strategies to inhibit signaling pathways initiat-
ing altered epithelial cell function in lung disease.
Vanadium compounds also occur in ROFA and may be
linked to the development of occupational asthma and
bronchitis. After inhalation of vanadium pentoxide
(V2O5), airway remodeling including mucous cell meta-
plasia and fibrosis, are observed in rodents [19]. Gene
profiling of lung fibroblasts exposed to V2O5 in vitro
reveals immediate increases in NADPH oxidase mRNA
levels accompanied by release of H2O2. These events pre-
cede early gene responses (1 to 4 hours) that include
increased mRNAs for number of growth factors (heparin-
binding epidermal growth factor or HB-EGF, etc.) and
later gene responses (after 12 hours) reflecting increased
expression of vascular endothelial growth factor (VEGF),
interleukins and receptors (IL-1R) and complement C9.
Transgenic models using COX-2 [20] or STAT-1 [21] null
mice [21] show that these mice are protected from V2O5 -
induced fibrosis. In vitro work suggests that epithelial pro-
duction of soluble mediators promotes proliferation and
collagen production by smooth muscle cells and fibrob-
lasts in this model of fibrogenesis.
Genetic linkage analysis of nickel-induced acute lung
injury in mice has identified as many as five interacting
loci that may be related to distinct pathophysiologic alter-
ations in this model. One transcriptional change is a large
increase in metallothionein (Mt) gene expression, a gene
in proximity to one of these linkage regions. Gene profil-
ing also reveals that genes involved in TGF-β1 signaling
and increases in TGF-β1 in bronchoalveolar lavage fluid
(BALF) are increased in mice inhaling nickel sulfate
whereas down-regulated genes include those involved in
lung fluid adsorption or surfactant and lipid synthesis
[22]. Mt 1/2 null mice are more susceptible to nickel-
induced pulmonary inflammation, injury, and lethality
than Mt 1+/2+ mice, whereas Mt-overexpressing trans-
genic mice have an increased survival rate [23]. Gene
expression associated with inflammation and changes in
extracellular matrix or coagulation/fibrinolysis is greater
in nickel-exposed Mt1/2 null mice compared to Mt 1+/2+
mice. These studies establish metallothionein as a protein
critical to host defense in acute lung injury by nickel.
Iron is an integral component of pathogenic amphibole
(crocidolite, amosite) asbestos fibers, occurs in samples of
PM, and is often a contaminant of silica dusts in South
African gold mines. Because iron drives a modified Haber-
Weiss or Fenton reaction leading to generation of
hydroxyl radical (. OH), it may contribute to the biologi-
cal reactivity of particle mixtures. For example, when aer-
osols of soot and iron particles in the ultrafine range are
inhaled by healthy adult rats, animals exposed to soot or
iron alone for 3 days have no adverse respiratory effects.
However, addition of approximately the same concentra-
tions of iron to soot in combined exposures causes syner-
gistic increases in pulmonary oxidative stress, elevations
in IL-1B and activation of the transcription factor nuclear
factor-κB (NF-κB), an oxidant-induced transcription fac-
tor [24]. These studies suggest that metals and particle
mixtures may have increased reactivity that may be more
than the sum of individual agents alone.
Metals such as chromium occur in mixtures of foundry
dusts or in PM and may sensitize airway epithelium to
injury from secondary insults such as arsenic or inflam-
matory cytokines. In vitro studies shows that CrVI sup-
presses activation of a number of transcription factors
(NF-κB, AP-1, Nrf2) in human airway epithelial cells that
led to loss of inducibility of protective genes encoding
proteins such as heme oxygenase-1 [25]. Although CrVI
suppresses many genes, it does not globally suppress con-
stitutive or inducible gene expression. However, CrVI
stimulates phosphorylation of STAT family proteins and
causes chronic induction of STAT-driven genes.
The silencing of protective genes required for defense
from secondary inflammatory insults by CrVI at nontoxic
concentrations may be a subtle effect occurring at low lev-
els of CrVI-containing particulates.
Mechanisms of asbestos-induced cell injury and 
remediation strategies
Asbestos fibers are causally linked to the development of
lung cancers, malignant mesotheliomas and pleural and
pulmonary fibrosis (asbestosis) and have been incorpo-
rated into thousands of industrial products worldwide.
Although asbestos has been banned in several Western
European countries, it continues to be used in developing
countries and persists in buildings and commerce. Tons of
naturally occurring asbestos fibers also exist in mineral
ores and soils, thus prevention of future asbestos-associ-
ated disease will depend largely upon new strategies for
remediation and detoxification of "in place" asbestos. We
have known for several years that the active iron ions on
amphibole types of asbestos, such as crocidolite or
amosite, cause sustained generation of reactive oxygen
species (ROS) that are related directly to fiber toxicity and
effects on DNA and proteins [26]. Moreover, some sam-
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ples of chrysotile asbestos contain small amounts of iron
that substitute for magnesium ions in its structure. Detoxi-
fication and removal of naturally occurring asbestos in an
outdoor environment or asbestos products in buildings
may require unique strategies. Several new approaches
requiring collaboration between chemists and biologists
include spontaneous polymerizations of natural products
on the surface of asbestos fibers and bioremediation by
soil fungi or lichens that adhere to fibers and selectively
remove iron [27]. These amorphous asbestos fibers may
prove to be less durable and non-pathogenic, requiring
validation in in vitro and animal testing.
Asbestos-associated diseases continue to be devastating
worldwide, and new biomarkers for early detection of
asbestos-induced cancers and fibrosis are sorely needed.
We continue to make progress on understanding the crit-
ical events in asbestos-induced carcinogenesis and fibro-
genesis with hopes of applying these findings to the
development of biomarkers and improved therapies for
individuals with lung cancer, mesothelioma and fibrosis.
Asbestos is a carcinogen that both damages DNA and
causes changes in the proliferation and differentiation of
target cells of lung and pleural diseases. Chromosomal
deletions and loss of tumor suppressor genes have been
reported in many mesotheliomas, and loss of Betaig (Big)-
h3 protein is frequent in primary lung carcinomas [28]. In
an immortalized human bronchial epithelial cell line,
chrysotile asbestos induced neoplastic transformation
and growth of cells in nude mice. Microarray studies
revealed that the BigH3 gene is consistently silenced in
tumor cells due to methylation of its promoter region. The
demonstration that re-expression of BigH3 suppresses
tumor growth suggests that this tumor suppressor gene
plays a critical role in fiber-induced carcinogenesis.
p53 is another tumor suppressor gene implicated in the
development of asbestos-induced mesotheliomas and
linked more recently to asbestos-induced mitochondrial
damage and apoptosis of alveolar epithelial cells [29].
Exciting results showed that amosite asbestos activates
p53 promoter activity and increased levels of p53 mRNA
and protein. Moreover, asbestos-induced p53 expression
in epithelial cells at the broncho-alveolar duct junctions
of asbestos-instilled rat lungs was blocked by phytic acid,
an iron chelator that may act directly on fibers or cells to
block redox reactions. The fact that p53-dependent tran-
scription regulates asbestos-induced apoptosis through a
mitochondrial death pathway that may be abrogated in
vivo by an iron chelator may have broad implications in
abrogating epithelial cell injury critical to the develop-
ment of fibrogenesis or carcinogenesis.
Several signaling pathways including NF-κB, Protein
kinase C, and the mitogen activated protein kinases
(MAPK) are activated in lung epithelial cells in vitro or
after inhalation of asbestos fibers. The extracellular signal
regulated kinases (ERK1/2) have been intensely studied
because this MAPK pathway, as opposed to the c-Jun-N-
terminal kinases (JNKs) or p38 cascades, is selectively
phosphorylated in lung epithelium by asbestos through a
redox-active process. The duration of ERK1/2 signaling
governs survival and death responses to both asbestos and
chemical generating systems of ROS and reactive nitrogen
species (RNS), presumably through events promoting
expression of cyclin D1 and cell cycle progression at low
concentrations, and stabilization of c-Fos in the cell
nucleus, preventing expression of cyclin D1 and promot-
ing epithelial apoptosis through apoptosis-inducing fac-
tor at higher, toxic concentrations [30]. Increased cyclin
D1 and Ki-67expression, an indication of cell cycle pro-
gression, are observed in mice after inhalation of chrys-
otile asbestos, and these markers of proliferation are
increased in asbestos-exposed MPO null mice in compar-
ison to MPO sufficient, wild type mice that exhibited
more lung inflammation [31]. These results suggest that
MPO as an oxidant generating enzyme primarily found in
neutrophils that may regulate epithelial responses to
asbestos.
The ERK1/2 pathway has recently been linked to down-
stream effects of Tumor necrosis factor-α(TNF α), a
cytokine critical to TGF-β1 expression [32]. TNFα receptor
null mice are resistant to chrysotile asbestos-induced
fibrosis, but overexpression of latent TGF-β1 prior to
inhalation of asbestos by TNFα receptor null-resistant
mice causes the development of lesions of the same sever-
ity observed in asbestos-exposed wild type mice. These
effects are attributed to oxidant-associated activation of
the latent TGF-β1 peptide suggesting a mechanism
through which ROS-generating particulates induce fibro-
genesis and lung remodeling. Global and lung epithelial
cell-specific targeting of ERK1/2 activation by pharmaco-
logic strategies and protein targeting might reveal whether
asbestos-induced epithelial cell responses and lung
remodeling are modified in murine models of asbestosis.
Occupational, environmental and genetic factors in the 
development of pulmonary disease by fibrogenic minerals 
and cigarette smoke
Like asbestos, respirable quartz particles and silica-con-
taining coal dusts may damage DNA at high concentra-
tions by eliciting DNA strand breakage and formation of
the oxidative DNA adduct, 8-hydroxydeoxyguanosine
(8OHdG), in lung epithelial cells in vitro that can be abro-
gated by surface coatings of quartz particles with polyvi-
nylpyrimidine-N-oxide or aluminum lactate. In vivo ROS
from inflammatory cells may also mediate DNA damage
or apoptosis in lung epithelium followed by enhanced
expression of the base excision repair protein, apurinic
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apyridiminic endonuclease (APE/Ref-1) [33]. Since APE-
1/Ref-1 has recently been functionally characterized as a
DNA repair enzyme in spontaneous DNA damage in
human cells [34], individual susceptibility to silica and
oxidant generating particulates may reflect the efficiency
of DNA repair by this and other pathways.
Inhaled silica and other particles such as residual oil fly
ash (ROFA) or stainless steel welding fumes (SSWF) that
generate ROS [35] may alter lung defense to bacterial and
other infections. In a rat bacterial infectivity model of Lis-
teria monocytogenes, pre-instillation of ROFA or SSWF
slowed lung clearance of bacteria and increased animal
morbidity, effects attributed to soluble and insoluble
metal components [36]. In contrast, silica-enhanced lung
bacterial clearance strikingly upregulated oxidant produc-
tion and activated neutrophils and alveolar macrophages
(AM) [37]. These results suggest that pro-oxidant effects of
metal components of pathogenic dusts may lead to
altered lung defense mechanisms in combating infec-
tions.
The AM is a critical cell type that is associated with lung
defense but also produces ROS in response to silica and
asbestos. Human and murine AM also undergo apoptosis
in response to silica, and silica-induced responses and
fibrosis in mice can be prevented by modulation of scav-
enger receptor A (CD204) and MARCO (another member
of the Class A scavenger receptors). Silica-induced apopto-
sis and ROS production that may be a consequence rather
than a cause of apoptosis are ablated in AM from CD204/
MARCO double null mice which continue to phagocytose
silica particles [38]. Another signaling pathway critical to
cytoskeleton-mediated quartz particle uptake in AMs is
one involving the FcγII receptor involving recruitment of
small GTPases in an actin-mediated process [presented by
P. Haberzettl, University of Dusseldorf, Dusseldorf, Ger-
many]. Use of cytochalasin B inhibits uptake of quartz,
ROS generation, and release of TNFα, suggesting a critical
link between particle uptake and production of inflamma-
tory mediators. Understanding how various receptors
(alone and together) signal responses of AM to fibrogenic
particles, possible cross-talk between these signaling path-
ways, and whether the distribution of scavenger and other
receptors differs in functionally different subsets of AM
will be critical to deciphering pro-inflammatory from
lung defense responses to inhaled particulates.
Cigarette smoke, a complex mixture of chemicals and par-
ticulates, is a co-factor in the development of asbestos and
silica-induced pulmonary fibrosis and lung cancers, and
rodent and human bronchial epithelial cells (1HAEo and
HBE1) in vitro exhibit alterations in differentiation includ-
ing induction of SPRR1B, a marker of squamous metapla-
sia that is an early lesion in the pathway to carcinoma.
Stimulation of the c-Jun and Fra-1 based activator-pro-
tein-1 (AP-1) transcription factor is a critical event leading
to squamous metaplasia in bronchial epithelial cells. In a
freshly generated mainstream smoke exposure model,
Fra-1 expression was regulated by a metalloproteinase
(MMP) and epidermal growth factor receptor (EGFR)-
dependent MAPK pathway. Another outcome of this cas-
cade is activation of a phosphoinositol-3-kinase (PI3K),
AKT-independent mechanism that appears to regulate
extracellular signal regulated kinase (ERK1/2) MAPK acti-
vation and subsequent Fra-1 [39]. In contrast, the tran-
scription factors, Elk-1 and cAMP response element
binding protein (CREB), appear to be more important in
cigarette smoke-regulated Fra-1 and AP-1 transactivation.
These studies show that multiple transcription factors
may cooperate in responses of bronchial epithelium to
inhaled toxic particles.
Both genetic and occupational/environmental factors
such as cigarette smoking and exposure to particulates are
critical to the development of pulmonary fibrosis. Com-
bined clinical studies and genomic profiling are likely to
reveal interactions between specific environmental agents
and genes predisposing to idiopathic pulmonary fibrosis
(IPF) and subtypes of idiopathic interstitial pneumonia
(IIP) [40]. In a recent study where families with two or
more cases of IIP occurred in first degree family members,
111 families with familial interstitial pneumonia (FIP)
having 301 affected and 360 unaffected individuals were
evaluated. After controlling for age and gender, smoking
was strongly associated with the development of FIP, and
20 pedigrees demonstrated vertical transmission consist-
ent with autosomal dominant inheritance, with some
pedigrees demonstrating several subtypes of IIP occurring
within the same families. These exciting results suggest
that gene-environmental interactions are critical to host
susceptibility in FIP and pulmonary fibrosis.
Nanoparticles and nanomedicine: a new and challenging 
frontier
Nanotechnology is the manipulation of matter on a near-
atomic size scale (~ 1–100 nm) to engineer new struc-
tures, materials, and devices. This technology will impact
numerous strategies in the field of cardiopulmonary med-
icine. Research in nanoscale materials is growing rapidly
worldwide, and by 2015, nanotechnology is expected to
have a one trillion dollar impact on the global economy.
Considering the rapid growth of nanotechnology and the
variety of nanomaterials potentially used in the future,
identifying, quantifying and managing potential health
risks is essential, especially in the respiratory tract that
may serve as the portal of entry for inhaled nanoparticles
and nanofibers.
Particle and Fibre Toxicology 2007, 4:4 http://www.particleandfibretoxicology.com/content/4/1/4
Page 7 of 10
(page number not for citation purposes)
Many published studies on PM or particles comprising
PM support the generalization that ultrafine particles are
more cytotoxic, inflammatory and fibrogenic on an equiv-
alent mass basis than fine-sized particles of the same com-
position. While the bioreactivity of ultrafine particles is
largely accepted as a probable indication of disease poten-
tial, the toxic potential of a nanoparticle is also affected by
surface treatments/coatings, degree of agglomeration, par-
ticle shape, and/or surface charge. It is likely that hazards
of newly designed nanoparticles will need to be evaluated
on a case-by-case basis once screening strategies are in
place [41].
Carbon nanotubes are a unique class of synthetic struc-
tures being evaluated for improved electrical, mechanical,
and thermal properties in the aerospace, electronic and
computer industries. After pharyngeal aspiration of sin-
gle-walled carbon nanotubes, a technique that introduces
a large bolus of fibers in contrast to more physiologic
inhalation routes, acute oxidant stress, inflammation, and
granulomas developing at deposition sites of nanotube
aggregates are observed [42]. Early-onset proximal fibrosis
and depletion of glutathione in bronchoalveolar lavage
fluid (BALF) occurs within seven days, and TGF-β1 levels
in BALF peak at seven days. Diffuse interstitial fibrosis
progressed from seven to 60 days in the distal lung, a phe-
nomenon attributed to translocation of nanotubes to dis-
tal alveolar septa. Experiments using aspiration of equal
mass amounts of ultrafine carbon black or silica revealed
less acute epithelial injury and neutrophil recruitment
than that observed with carbon nanotubes, suggesting dif-
ferent kinetics of lung injury. Although particle delivery in
these studies appears more diffuse than intratracheal
instillation studies, inhalation studies using lower dose
ranges of nanomaterials over time are advocated for more
precise evaluation of toxicity in relevant airborne expo-
sures.
Although it is clear that the lung will be an initial target of
inhaled nanomaterials, their small size enables their
translocation via pulmonary capillaries and other mecha-
nisms to systemic sites. Thus, revealing the systemic effects
of nanoparticles in the vasculature, distal organs and sen-
sory nervous system, since it has been shown that
ultrafine particles can be transported to the olfactory bulb
in the brain via sensory nerves in the nasal cavity [43], is
critical to understand the systemic effects of nanoparticles
in the vasculature, distal organs and sensory nervous sys-
tem. The derivation of pulmonary and cardiovascular
effects of combustion-derived nanoparticles (CDNP),
such as diesel exhaust particles and welding fumes [44],
appear to follow paradigms previously documented with
asbestos and silica as well as metal-containing PM,
namely that oxidative stress and inflammation are critical
to the initiation of adverse pulmonary reactions. The con-
tribution and identification of inflammatory mediators
generated in the lung or BALF and/or after translocation of
ultrafine or nanoparticles from the lung to blood, lym-
phatics and other organs need definition. Another critical
target may be endothelial cells as inhalation of diesel
exhaust particles alters endothelial function in the sys-
temic circulation. The origin of changes in autonomic
innervation, heart rate variability, and electrical activity of
the brain, measured by quantitative EEG approaches in
healthy human volunteers inhaling diesel exhaust, may
also involve a combination of systemic effects induced by
inhaled and translocated ultrafine particles [B. Crut et al.,
Zuyd University, Heerlen, The Netherlands, manuscript in
preparation].
The large internal and external surface area of synthetic
nanoparticles makes them useful tools for drug delivery to
the lung and heart. In addition, labeled or magnetic nan-
oparticles can be employed in high resolution imaging to
increase local retention and proliferation of fibroblasts
after intra-arterial injections targeting ischemia [presented
by PJA Borm, Zuyd University, Heerlen, The Netherlands].
Although the extremely small size of nanomaterials per-
mits their entry into the circulation and transport poten-
tially to other organs where uptake may also occur,
synthetic particles can be engineered in larger size ranges
with defined pore dimensions for optimum drug delivery
and direct targeting to lung or pleura. Thus nebulization
or intrapleural injection circumvents systemic drug toxic-
ity, a central problem in patients with lung cancers and
mesotheliomas. Acid-prepared mesoporous spheres
(APMS) (1–2 micron diameter with 40 A diameter pores)
have been examined in preclinical studies and are non-
toxic and noninflammatory after intrapleural injection or
intranasal administration into mice [45]. APMS increases
both the delivery and killing potency of doxorubicin
(DOX) in human mesothelioma cells and are phagocy-
tized by an actin-dependent process evading phagolyso-
somes. Tumor prevention studies in a nude mouse
xenograft model using human mesotheliomas are cur-
rently in progress. These approaches and studies summa-
rized above using nanomaterials are strengthened by
collaborations between chemists, biologists, toxicologists,
and clinicians.
Conclusion
Occupational exposures to inhaled pathogenic particles
and fibers such as silica and asbestos have been associated
with the development of lung inflammation and disease.
The development of lung fibrosis and cancer by these nat-
urally occurring minerals is dose and time-related with
relatively long durations of exposure. In the last decade,
epidemiology and animal models have revealed acute
morbidity and mortality, including exacerbation of
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asthma and toxic effects extending to the cardiovascular
system, from episodic exposures to PM. Dissecting the
adverse components of PM and mechanistic events occur-
ring in the lung, its initial site of deposition, and systemi-
cally is daunting because of the complexity and
seasonable variability of PM. However, ultrafine particles
and components such as metals (iron, vanadium, zinc,
etc.), sulfates, and adsorbed hydrocarbons may act
uniquely or synergistically and/or render the lung more
sensitive to secondary insults. The majority of experimen-
tal data suggests that size and pro-oxidation state of PM
determine its overall distribution and durability in lung
and distal organs, cell/tissue transport mechanisms and
toxic potential. This information may be vital to the
design and use of "safe" synthetic nanoparticles and
nanofibers, a burgeoning technology.
Proinflammatory and acute effects of PM are directly
related to oxidative stress and induction of multiple oxi-
dant or xenobiotic-induced signaling cascades and tran-
scription factors (NF-κB, AP-1, Nrf2), a paradigm
consistent with models of asbestos and silica-associated
lung diseases. An important consequence of initial oxi-
dant injury is the antioxidant response that when over-
whelmed or compromised in subjects with weakened
defenses, i.e., individuals with single nucleotide polymor-
phisms or changes in expression of antioxidant enzymes,
the GSTM1 gene, etc., predisposes to cardiopulmonary
morbidity or mortality. Information on other host suscep-
tibility factors and genes predisposing to the development
of acute and chronic diseases by inhaled particles may be
obtained by genotype and phenotype analyses.
Knowledge of the events leading to systemic transport and
pathogenicity of PM, including impairment of vascular
and fibrinolytic function, is also vital to preventive
approaches in the public health domain. The presenta-
tions summarized above suggest a number of potential
mechanisms whereby PM may adversely affect the cardio-
vascular system by altering autonomic function, vascular
reactivity, and thrombosis. However, how these effects
contribute to and whether they are related causally to the
pathogenesis of atherosclerosis are unclear. Another
important question that needs to be addressed is whether
the physical presence of PM is required for distal organ
effects or whether these effects are mediated by lung
chemokines, cytokines or inflammatory cells after inhala-
tion of PMs. Moreover, the many physical and chemical
properties of PM and other inhaled particulates that are
central to their pathogenicity need to be elucidated.
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